DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCC
Clinical trial NCT00085436 · COMPLETED
Trial details
- NCT number
- NCT00085436
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-12-01
- Primary completion
- 2009-10-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.